ST. PAUL, Minn., July 28 /PRNewswire/ -- Diametrics Medical, Inc. (Nasdaq-NNM: DMED) has announced plans to incorporate blood glucose monitoring in its IRMA(R) SL Blood Analysis System through an agreement with LifeScan, a Johnson & Johnson company, (NYSE: JNJ), the leading maker of blood glucose monitoring systems for people with diabetes.

The IRMA SL Blood Analysis System, used in hospitals worldwide, is a hand-held blood analyzer that measures critical blood gas, electrolyte and hematocrit levels immediately at the patient's bedside. The integration of LifeScan's SureStep(R) technology into the IRMA SL analyzer will give medical professionals a system that can also measure a patient's blood glucose level -- critical information that is necessary for medical decisions. The system collects and displays the comprehensive test results on the IRMA SL display screen. The data is captured, stored and exported to the IRMA Data Management System (IDMS) and/or the hospital's clinical information system and included in the permanent patient record.

"Our simple and accurate SureStep technology, also used in one of our consumer products, will offer a new level of convenience in blood glucose monitoring for hospitals using the IRMA SL system," said John Klopp, LifeScan's Vice President of Business Development. "Its patented test strip technology provides advanced safety features like true off-meter dosing that allows blood to be applied to the absorbent test strip before it is inserted into the meter to minimize the risk of cross contamination and infection. The test strip also features a unique color confirmation dot that indicates when enough blood has been applied to help ensure accurate results in as little as fifteen seconds."

"Such a collaboration provides clinicians with a unique, portable, economical bedside source for glucose, blood gas, electrolytes and hematocrit testing," said David Giddings, Diametrics Chairman and Chief Executive Officer. "The agreement with LifeScan is an example of how both companies are actively pursuing opportunities to improve the diagnostic options available to clinicians."

The combined product is expected to be available in some countries by the fourth quarter of 1997. The companies will also collaborate on worldwide sales and marketing efforts including activities at professional meetings and communication efforts to inform, support and educate customers.

Diametrics Medical, Inc., is a leader in critical care technology. The company is dedicated to creating solutions that improve the quality of health care delivery through products and services that provide immediate, accurate and cost-effective time-critical blood analysis. Additional information is available at the company's Web site, http://www.diametrics.com

LifeScan, a Johnson & Johnson company, is the leading maker of blood glucose monitors for people with diabetes. For home and hospital use, LifeScan systems help healthcare professionals and their patients determine the effectiveness of prescribed medication, diet and exercise programs. More doctors, diabetes educators and pharmacists recommend LifeScan systems than any other brand.

Press Release Index

Home | Company | Products | Diabetes Care | Hospital Products | Feedback | Around the World

The health information on this Web site is for general background purposes and is not a substitute for medical advice or treatment for specific conditions. Seek prompt medical attention for health care questions you have. Consult your physician before making changes to your medication, diet, fitness program, or blood glucose testing schedules.

This site is intended for visitors from the United States and published by LifeScan, Inc., which is solely responsible for its contents.
By using this site, you agree to our Legal Notice and Privacy Policy.
AdvaMed Guidelines.
© LifeScan, Inc. 1996-. All trademarks are the property of their respective owners.                                                                                         AW 3071010C